Temperature and Pain in Laparoscopy
Launched by RWTH AACHEN UNIVERSITY · May 19, 2016
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
During the first 30 to 40 minutes of anaesthesia, a patient's temperature can drop to below 35.0°C. Reasons for this include loss of the behavioural response to cold and the impairment of thermoregulatory heat-preserving mechanisms under general or regional anaesthesia, anaesthesia-induced peripheral vasodilation, the use of cold dry insufflation gases. For these reasons, institutions employ a range of techniques to prevent hypothermia, including forced air warming (peri-operatively), use of warmed intravenous fluids, temperature monitoring and control of room temperature. Despite these int...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 18 years or above and aged under 70 years
- • Written informed consent prior to study participation
- • Patients admitted to hospital for laparoscopic surgery with a planned duration of more than 1 hour; if there is an open component to the surgery then this should be discussed, in terms of the length of the laparoscopic component
- • BMI \<35
- Exclusion Criteria:
- • Pregnancy or women without sufficient contraception
- • Women, who are breastfeeding
- • Alcohol or drug abuse
- • Expected non-compliance
- • Patients unwilling or unable to give informed consent, patients with limited ability to comply with instructions for this study
- • Participation on another interventional study within the last 3 months
- • Subjects who are committed to an institution and/or penitentiary by judicial or official order
- • Employees of the investigator cooperation companies
About Rwth Aachen University
RWTH Aachen University is a prestigious research institution located in Aachen, Germany, renowned for its commitment to advancing science and technology through innovative research and education. As a clinical trial sponsor, RWTH Aachen University leverages its interdisciplinary expertise and state-of-the-art facilities to conduct cutting-edge clinical research aimed at improving patient outcomes. The university collaborates with various healthcare stakeholders to facilitate the translation of scientific discoveries into effective therapeutic interventions, ensuring adherence to ethical standards and regulatory requirements throughout the research process. With a focus on fostering knowledge exchange and driving clinical advancements, RWTH Aachen University plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aachen, Nrw, Germany
Patients applied
Trial Officials
Julia Wittenborn, Dr. med.
Principal Investigator
Uniklink RWTH Aachen, Klinik für Gynäkologie und Geburtsmedizin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials